- জেনেরিক নাম
- Letrozole
- শক্তি
- 2.5 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Nuvista Pharma Ltd
৳ ৪২.১৪ ৳ ৪৩.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
Zoleta 2.5 mg Tablet একটি ট্যাবলেট ঔষধ, যার জেনেরিক নাম Letrozole এবং শক্তি ২.৫ mg। এই ব্র্যান্ডের প্রস্তুতকারক Nuvista Pharma Ltd। Letrozole-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। Zoleta-এর প্রতি ইউনিটের দাম ৪৩ টাকা। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Letrozole-এর ৭টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ৪টি। সবচেয়ে কম দাম Ovazol 2.5 mg Tablet-এর, প্রতি ইউনিট ৳ ৪০.০০।
Zoleta 2.5 mg tablet is a hormonal chemotherapy medicine. It contains letrozole and is made by Nuvista Pharma Ltd. Doctors use it to treat advanced or metastatic breast cancer that is hormone receptor positive or of unknown receptor status in women who have gone through menopause. Letrozole is an aromatase inhibitor: it reduces the amount of oestrogen the body makes, which can slow the growth of cancers that depend on oestrogen. The doctor decides the dose and how long treatment continues.
Zoleta is used for first-line treatment of advanced or metastatic breast cancer in post-menopausal women when the cancer is hormone receptor positive or the receptor status is unknown. It is not for pre-menopausal women. The doctor will confirm whether this medicine is appropriate based on the cancer type and menopausal status. The dose and course are set by the doctor.
Take Zoleta exactly as your doctor tells you. The tablet is usually taken by mouth, and your doctor will decide the dose and how long you continue treatment. Do not change the dose or stop on your own. If you miss a dose, ask your doctor or pharmacist what to do. Swallow the tablet with water; you can take it with or without food unless your doctor advises otherwise. Keep the medicine stored as directed.
Many side effects of Zoleta are mild to moderate. Commonly reported ones include muscle and joint pain, headache, tiredness, nausea, vomiting, constipation, diarrhoea, rash, abdominal pain, indigestion, loss of appetite, cough, shortness of breath, swelling of the ankles, chest pain, and hot flushes or hair thinning. Dizziness, weight gain and itching are less common. Tell your doctor if side effects bother you or do not go away. Seek urgent help for severe or sudden symptoms.
Zoleta is not for women who are pregnant, breastfeeding, or pre-menopausal. It is also not for people with severe liver problems or allergy to letrozole or similar medicines. Before starting, tell your doctor about any liver or kidney problems, all other medicines you take, and any allergies. The doctor will decide if it is suitable for you. Do not use it during pregnancy or breastfeeding. Ask your doctor about precautions and monitoring during treatment.
Zoleta is a hormonal chemotherapy for advanced or metastatic breast cancer in post-menopausal women with hormone receptor positive or unknown receptor status. It contains letrozole, an aromatase inhibitor that lowers oestrogen production. The doctor decides the dose and course.
Watch for muscle or joint pain, headache, tiredness, nausea, vomiting, constipation, diarrhoea, rash, swelling, cough, or shortness of breath. Call your doctor if these bother you or persist. Seek urgent help for severe or sudden symptoms. Your doctor can advise on management.
No. Zoleta is not recommended during pregnancy or breastfeeding. It is contraindicated in pregnancy and lactation. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. The doctor will discuss suitable options.
The listed price is ৳ ৪৩.০০.
৳ ৪২.১৪ ৳ ৪৩.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Letrozole is indicated for the first-line treatment of advanced/metastatic breast cancer (hormone receptor positive or receptor status unknown) in post-menopausal women.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Mechanism of Action: Letrozole is a potent and highly specific nonsteroidal aromatase inhibitor. It inhibits the aromatase enzyme by competitively binding to the haem of the cytochrome P450 subunit of the enzyme, resulting in a reduction of estrogen biosynthesis in all tissues. Letrozole exerts its antitumor effect by depriving estrogen-dependent breast cancer cells of their growth stimulus. In postmenopausal women, estrogens are derived mainly from the action of the aromatase enzyme, which coverts adrenal androgens primarily androstenedione and testosterone-to oestrone (E1) and oestradiol (E2). The suppression of estrogen biosynthesis in the peripheral tissues and the malignant tissues can be achieved by specifically inhibiting the aromatase enzyme.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The recommended dose of Letrozole is 2.5 mg once daily. Treatment with Letrozole should continue as long as tumor response is seen. The drug should be discontinued if tumor stops responding as judged by tumor progression. For elderly patients, no modification of the normal adult dosage regimen is necessary. No dosage adjustment is required for patients with mild to moderate hepatic impairment or renal impairment.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Clinical interaction studies with cimetidine and warfarin indicated that the co-administration of letrozole with these drugs does not result in clinically significant drug reactions, even through cimetidine is a known inhibitor of one of the cytochrome P450 isoenzymes capable of metabolising letrozole in vitro.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Letrozole is contraindicated in known or suspected hypersensitivity to letrozole, other aromatase inhibitors, or to any of their ingredients. It is contraindicated during pregnancy, lactation and in pre-menopausal women. It is also contraindicated in severe hepatic dysfunction.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Adverse events associated with letrozole are generally mild to moderate and rarely severe enough to require discontinuation. Many can be attributed to either the underlying disease or the normal pharmacological consequence of oestrogen deprivation (hot flushes, hair thinning). The most frequently reported adverse events are musculoskeletal pain, arthralgia, headache, fatigue, nausea, dyspnoea, peripheral oedema, coughing, constipation, vomiting, chest pain, viral infection, diarrhoea, rash, abdominal pain, dyspepsia and anorexia. Dizziness, weight increase and pruritus are less commonly seen.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Oral administration of letrozole in pregnant rats resulted in teratogenicity and maternal toxicity at 0.03 mg/kg. Embryotoxicity and foetotoxicity were seen at doses >0.003 mg/kg and there was an increase in the incidence of foetal malformation among the animals treated. However, there are no adequate and well-controlled studies of letrozole in pregnant women and its use in these patients is not recommended. It is not known whether letrozole is excreted in human milk. Because many drugs are excreted in human milk, letrozole should not be administered to a nursing woman.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In breast cancer patients with moderate hepatic dysfunction, no dosage adjustment is necessary, but caution is recommended since letrozole elimination depends mainly on intrinsic metabolic clearance. Renal impairment (calculated creatinine clearance: 20 to 50 ml/min) did not affect steady-state plasma letrozole concentration at a dose of 2.5 mg or 5 mg. Hence, no dose adjustment is necessary for such renal function impairment. It is anticipated that letrozole could be removed from blood by dialysis since it is weakly bound to plasma proteins. The potential risks and benefits to such patients should be considered carefully before prescribing letrozole. In some cases, fatigue and dizziness have been observed with the use of letrozole. Patients should therefore, be advised that their physical and/or mental abilities required for operating machinery or driving a car may be impaired.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is no clinical experience of overdosage. There is no specific antidote to letrozole. Since letrozole is not highly protein-bound, dialysis may be helpful. Emesis may be induced if the patient is alert. In general, supportive care and frequent monitoring of vital signs is appropriate.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।